Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-01-31
2006-01-31
Saeed, Kamal A. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S342000, C514S369000, C546S280400, C548S183000
Reexamination Certificate
active
06992191
ABSTRACT:
Provided is a method of hydrogenating the exocyclic double bond of a thiazolidinedione precursor in a method of making a thiazolidinedione antihyperglycemic, for example pioglitazone, including work-up steps to afford pure thiazolidinedione antihyperglycemic.
REFERENCES:
patent: 5002953 (1991-03-01), Hindley
patent: 5710152 (1998-01-01), Nagao et al.
patent: 5952509 (1999-09-01), Saito et al.
patent: 6248363 (2001-06-01), Patel et al.
J. Cossy et al., “A Short Synthesis of Troglitazone: An Antidiabetic Drug for Treating Insulin Resistance,” Bioorganic and Medicinal Chemistry Letters 9, pp. 3439-3440 (1990).
Shigeo Nishimura,Handbook of Heterogeneous Catalytic Hydrogenation for Organic Synthesis, Chapter 1, pp. 1-51 (2001).
Kenyon & Kenyon
Saeed Kamal A.
Teva Pharmaceutical Industries Ltd.
LandOfFree
Hydrogenation of precursors to thiazolidinedione... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrogenation of precursors to thiazolidinedione..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrogenation of precursors to thiazolidinedione... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3541672